Neurocrine Biosciences Total Liabilities and Share Holders Equity 2010-2025 | NBIX
Neurocrine Biosciences total liabilities and share holders equity for the quarter ending March 31, 2025 was $3.688B, a 6.2% increase year-over-year.
- Neurocrine Biosciences total liabilities and share holders equity for 2024 was $3.719B, a 14.37% increase from 2023.
- Neurocrine Biosciences total liabilities and share holders equity for 2023 was $3.251B, a 37.27% increase from 2022.
- Neurocrine Biosciences total liabilities and share holders equity for 2022 was $2.369B, a 14.29% increase from 2021.